• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Anti Inflammatory Peptide Market

    ID: MRFR/HC/38852-HCR
    128 Pages
    Rahul Gotadki
    October 2025

    Anti-inflammatory Peptide Market Research Report By Mechanism of Action (NF-B Inhibition, JAK/STAT Inhibition, Interleukin Inhibition, TNF- Inhibition), By Indication (Rheumatoid Arthritis, Osteoarthritis, Gout, Multiple Sclerosis), By Source (Animal Origin, Plant Origin, Microbial Origin), By Route of Administration (Injections, Oral, Topical) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Anti Inflammatory Peptide Market Infographic
    Purchase Options

    Anti Inflammatory Peptide Market Summary

    The Global Anti-inflammatory Peptide Market is projected to grow significantly from 6.2 USD Billion in 2024 to 21.3 USD Billion by 2035.

    Key Market Trends & Highlights

    Anti-inflammatory Peptide Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 11.89 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 21.3 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 6.2 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of anti-inflammatory peptides due to increasing health awareness is a major market driver.

    Market Size & Forecast

    2024 Market Size 6.2 (USD Billion)
    2035 Market Size 21.3 (USD Billion)
    CAGR (2025-2035) 11.89%

    Major Players

    Amgen, AbbVie, Johnson Johnson, GlaxoSmithKline, Roche, Bristol-Myers Squibb, Novartis, Celgene, Peptron, Pfizer, Bayer, Sanofi, Merck, Eli Lilly and Company

    Anti Inflammatory Peptide Market Trends

    The Global Anti-Inflammatory Peptide Market is expected to grow due to increasing cases of inflammatory-related disorders, increasing efforts towards r&d and advancements in the biotechnological sector. Important market growth factors have been the awareness of being able to use peptides to modulate inflammation, an increasing number of peptides being developed that have better efficacy and selectivity, and the growing use of non-steroidal anti-inflammatory drugs (NSAIDs).

    The increasing prevalence of chronic inflammatory diseases is driving a notable interest in anti-inflammatory peptides as potential therapeutic agents, suggesting a transformative shift in treatment paradigms.

    National Institutes of Health (NIH)

    Anti Inflammatory Peptide Market Drivers

    Market Growth Projections

    The Global Anti-inflammatory Peptide Market Industry is projected to experience substantial growth over the next decade. In 2024, the market is expected to reach 6.2 USD Billion, with forecasts indicating a rise to 21.3 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 11.89% from 2025 to 2035, reflecting increasing investments in research and development, rising consumer demand for health products, and advancements in peptide technology. Such projections underscore the potential for anti-inflammatory peptides to play a pivotal role in future healthcare solutions.

    Advancements in Biotechnology

    Technological advancements in biotechnology are significantly influencing the Global Anti-inflammatory Peptide Market Industry. Innovations in peptide synthesis and purification techniques have enhanced the efficiency and efficacy of anti-inflammatory peptides. These advancements enable the development of novel therapeutic agents that can target specific inflammatory pathways, potentially leading to more effective treatments with fewer side effects. As a result, the market is expected to grow substantially, with projections indicating a rise to 21.3 USD Billion by 2035. This growth underscores the importance of continued investment in biotechnological research and development to harness the full potential of anti-inflammatory peptides.

    Increasing Consumer Awareness

    Consumer awareness regarding the benefits of anti-inflammatory peptides is on the rise, contributing to the expansion of the Global Anti-inflammatory Peptide Market Industry. As individuals become more informed about the health implications of inflammation and the potential of peptides as natural remedies, there is a growing demand for products that incorporate these compounds. This trend is particularly evident in dietary supplements and functional foods, where consumers seek out ingredients that promote health and wellness. The market's growth trajectory, with a projected CAGR of 11.89% from 2025 to 2035, indicates that this heightened awareness is likely to drive significant sales in the coming years.

    Rising Prevalence of Chronic Diseases

    The Global Anti-inflammatory Peptide Market Industry is experiencing growth due to the increasing prevalence of chronic diseases such as arthritis, diabetes, and cardiovascular disorders. These conditions often involve inflammatory responses that can be mitigated by anti-inflammatory peptides. As the global population ages, the incidence of these diseases is likely to rise, driving demand for effective therapeutic options. In 2024, the market is projected to reach 6.2 USD Billion, reflecting a growing recognition of the role of peptides in managing inflammation. This trend suggests a robust future for the industry as healthcare systems seek innovative solutions to address chronic health challenges.

    Regulatory Support for Peptide Therapies

    Regulatory bodies are increasingly recognizing the therapeutic potential of anti-inflammatory peptides, which is positively impacting the Global Anti-inflammatory Peptide Market Industry. Supportive regulatory frameworks facilitate the approval process for peptide-based therapies, encouraging pharmaceutical companies to invest in research and development. This regulatory backing not only enhances the credibility of peptide therapies but also fosters innovation within the industry. As a result, the market is poised for growth, with expectations of reaching 21.3 USD Billion by 2035. This trend highlights the importance of collaboration between regulatory agencies and industry stakeholders to advance peptide-based solutions.

    Emerging Applications in Sports Nutrition

    The Global Anti-inflammatory Peptide Market Industry is witnessing emerging applications in sports nutrition, as athletes and fitness enthusiasts increasingly seek products that aid recovery and reduce inflammation. Anti-inflammatory peptides are being incorporated into supplements designed to enhance performance and support muscle recovery post-exercise. This trend is driven by a growing understanding of the role of inflammation in athletic performance and recovery. As the market evolves, it is anticipated that the demand for such products will contribute to the overall growth of the industry, with projections indicating a CAGR of 11.89% for 2025 to 2035.

    Market Segment Insights

    Anti-inflammatory Peptide Market Segment Insights:

    Anti-inflammatory Peptide Market Segment Insights:

    Anti-inflammatory Peptide Market Mechanism of Action Insights  

    Anti-inflammatory Peptide Market Mechanism of Action Insights  

    The Global Anti-inflammatory Peptide Market segmentation by Mechanism of Action includes NF-B Inhibition, JAK/STAT Inhibition, Interleukin Inhibition, and TNF- Inhibition. Among these, the NF-B Inhibition segment held the largest market share in 2023 and is expected to continue its dominance during the forecast period. The growth of this segment can be attributed to the increasing prevalence of inflammatory diseases, such as rheumatoid arthritis and Crohn's disease. The JAK/STAT Inhibition segment is also expected to witness significant growth during the forecast period, owing to the rising adoption of JAK inhibitors for the treatment of autoimmune diseases.

    The Global Anti-inflammatory Peptide Market data shows that the Interleukin Inhibition segment is expected to grow at a steady pace during the forecast period. This growth can be attributed to the increasing use of interleukin inhibitors for the treatment of inflammatory diseases, such as psoriasis and multiple sclerosis. The TNF-inhibition segment is also expected to witness moderate growth during the forecast period, owing to the increasing use of TNF inhibitors for the treatment of inflammatory diseases, such as rheumatoid arthritis and Crohn's disease.

    The growth of the Global Anti-inflammatory Peptide Market is attributed to the increasing prevalence of inflammatory diseases, the rising adoption of targeted therapies, and the growing demand for personalized medicine. The market is also expected to benefit from the increasing investment in research and development activities by pharmaceutical companies.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Anti-inflammatory Peptide Market Indication Insights  

    Anti-inflammatory Peptide Market Indication Insights  

    The global Anti-inflammatory Peptide Market is segmented into various indications, including Rheumatoid Arthritis, Osteoarthritis, Gout, and Multiple Sclerosis. Among these, Rheumatoid Arthritis accounted for the largest revenue share in 2023, owing to the high prevalence of the condition and the availability of effective treatments. 

    The Osteoarthritis segment is also expected to witness significant growth due to the rising geriatric population, which is more susceptible to this condition. Gout and Multiple Sclerosis are other key indications that are driving the growth of the Anti Inflammatory Peptide Market.The increasing prevalence of these conditions, coupled with the growing demand for effective treatments, is expected to fuel the growth of this segment in the coming years.

    Anti-inflammatory Peptide Market Source Insights  

    Anti-inflammatory Peptide Market Source Insights  

    The Global Anti-inflammatory Peptide Market segmentation by Source is categorized into Animal Origin, Plant Origin, and Microbial Origin. Among these segments, Animal Origin held the largest market share in 2023, accounting for around 45.0% of the Global Anti-inflammatory Peptide Market revenue. The increasing demand for animal-derived peptides drives the growth of this segment due to their high biological activity and specificity. Plant Origin is expected to witness significant growth over the forecast period, owing to the growing adoption of plant-based products and the rising prevalence of veganism.

    Microbial Origin is projected to grow at a steady pace, driven by the advancements in biotechnology and the increasing use of microbial peptides in therapeutic applications.

    Anti-inflammatory Peptide Market Route of Administration Insights  

    Anti-inflammatory Peptide Market Route of Administration Insights  

    Injections accounted for the largest revenue share of the global Anti-inflammatory Peptide Market in 2023, and this trend is projected to continue during the forecast period. This dominance can be attributed to the high efficacy and targeted delivery of anti-inflammatory peptides via injections. Injections allow for precise administration of the therapeutic directly into the affected area or bloodstream, ensuring rapid onset of action and sustained therapeutic effects. Moreover, injections are suitable for treating various conditions, including rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease.

    Oral administration is another significant route of administration for anti-inflammatory peptides. Oral formulations offer convenience and ease of administration, making them suitable for long-term therapies. However, oral bioavailability of peptides can be limited due to degradation in the gastrointestinal tract. Research efforts are focused on developing novel delivery systems to enhance oral bioavailability and improve the efficacy of anti-inflammatory peptides. Topical administration of anti-inflammatory peptides is gaining traction due to its non-invasive nature and targeted delivery to the affected area.

    Topical formulations, such as creams, ointments, and gels, can effectively treat skin conditions, including psoriasis, eczema, and burns. They offer localized delivery of the therapeutic, minimizing systemic exposure and potential side effects.

    Get more detailed insights about Anti Inflammatory Peptide Market

    Regional Insights

    The Global Anti-inflammatory Peptide Market is segmented into North America, Europe, APAC, South America, and MEA. North America is expected to hold the largest market share in 2023, owing to the presence of a large number of pharmaceutical companies and research institutions, with a market value of 2.042 billion USD, rising to 5.186 billion USD by 2032.

    Europe is expected to be the second-largest market, with a value of 2.042 billion USD in 2023 and 5.024 billion USD in 2032, followed by APAC, which is expected to witness a market value of 0.766 billion USD in 2023 and grow to 3.369 billion USD by 2032. 

    South America and MEA are expected to account for a smaller share of the global market, with South America valued at 0.278 billion USD in 2023 and 0.729 billion USD in 2032, and MEA at 0.371 billion USD in 2023 and 0.891 billion USD in 2032.

    Anti-inflammatory Peptide Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    Major players in the Anti-inflammatory Peptide Market are focusing on developing innovative products and expanding their product portfolio. Leading Anti-inflammatory Peptide Market players are also investing in research and development to improve the efficacy and safety of their products. The presence of a few large players and a number of small and medium-sized players characterizes the Anti-inflammatory Peptide Market industry. 

    The competitive landscape of the Anti-inflammatory Peptide Market is expected to remain fragmented in the coming years, with the leading players continuing to dominate the market. However, the entry of new players and the expansion of existing players into new markets is expected to intensify competition in the Anti Inflammatory Peptide Market.

    A leading company in the Global Anti-inflammatory Peptide Market is Amgen. The company is a global leader in the development and manufacture of pharmaceuticals, including biologics. Amgen's Anti-inflammatory Peptide Market products include Enbrel, which is used to treat rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The company also markets Otezla, which is used to treat plaque psoriasis and psoriatic arthritis. Amgen is committed to research and development, and the company has a strong pipeline of new Anti-inflammatory Peptide Market products in development.

    A competitor company in the Global Anti-inflammatory Peptide Market is AbbVie. The company is a global leader in the development and manufacture of pharmaceuticals, including biologics. AbbVie's Anti-inflammatory Peptide Market products include Humira, which is used to treat rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The company also markets Skyrizi, which is used to treat plaque psoriasis and psoriatic arthritis. AbbVie is committed to research and development, and the company has a strong pipeline of new Anti-inflammatory Peptide Market products in development.

    Key Companies in the Anti Inflammatory Peptide Market market include

    Industry Developments

    The Anti-Inflammatory Peptide Market is poised to expand significantly over the forecast period, driven by the rising prevalence of chronic inflammatory diseases, increasing demand for targeted therapies, and advancements in peptide-based drug development. Key players in the market include Novartis, Amgen, Merck, and Pfizer. Recent developments include the approval of new anti-inflammatory peptide drugs, such as Amgen's Parsabiv and Chinook Therapeutics' BPR4 antagonist. Additionally, ongoing research into the role of peptides in immune regulation and inflammation is expected to fuel future market growth.

    Future Outlook

    Anti Inflammatory Peptide Market Future Outlook

    The Global Anti-inflammatory Peptide Market is projected to grow at 11.89% CAGR from 2024 to 2035, driven by rising chronic diseases, advancements in biotechnology, and increasing consumer awareness.

    New opportunities lie in:

    • Develop targeted peptide therapies for autoimmune disorders to capture niche markets.
    • Invest in sustainable sourcing of peptide ingredients to enhance brand value.
    • Leverage digital health platforms for personalized peptide-based treatments and patient engagement.

    By 2035, the market is expected to exhibit robust growth, positioning itself as a leader in innovative therapeutic solutions.

    Market Segmentation

    Anti-inflammatory Peptide Market Source Outlook

    • Animal Origin
    • Plant Origin
    • Microbial Origin

    Anti-inflammatory Peptide Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia-Pacific
    • Middle East and Africa

    Anti-inflammatory Peptide Market Indication Outlook

    • Rheumatoid Arthritis
    • Osteoarthritis
    • Gout
    • Multiple Sclerosis

    Anti-inflammatory Peptide Market Mechanism of Action Outlook

    • NF-B Inhibition
    • JAK/STAT Inhibition
    • Interleukin Inhibition
    • TNF- Inhibition

    Anti-inflammatory Peptide Market Route of Administration Outlook

    • Injections
    • Oral
    • Topical

    Report Scope

    Report Attribute/Metric Details
    Market Size 2022 4.91(USD Billion)
    Market Size 2023 5.5(USD Billion)
    Market Size 2032 15.2(USD Billion)
    Compound Annual Growth Rate (CAGR) 11.96% (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 – 2022
    Market Forecast Units USD Billion
    Key Companies Profiled Johnson  Johnson, GlaxoSmithKline, Roche, Bristol-Myers Squibb, Novartis, Celgene, Amgen, AbbVie, Peptron, Pfizer, Bayer, Sanofi, Merck  Co., Eli Lilly and Company
    Segments Covered Mechanism of Action, Indication, Source, Route of Administration, Regional
    Key Market Opportunities Chronic Inflammatory Diseases Treatment Joint Pain Management Inflammatory Skin Conditions
    Key Market Dynamics Increasing demand for natural and targeted therapies Growing prevalence of chronic inflammatory diseases Favorable regulatory landscape for peptide-based drugs Advancements in peptide synthesis and delivery technologies Rising focus on personalized medicine
    Countries Covered North America, Europe, APAC, South America, MEA

    FAQs

    What is the projected CAGR of the Global Anti Inflammatory Peptide Market?

    The Global Anti-inflammatory Peptide Market is expected to Register a CAGR of 11.96% from 2024 to 2032.

    What is the expected market size of the Global Anti-inflammatory Peptide Market in 2032?

    The Global Anti-inflammatory Peptide Market is expected to reach a valuation of 15.2 Billion USD by 2032.

    Which region is expected to hold the largest market share in the Global Anti Inflammatory Peptide Market?

    North America is expected to hold the largest market share in the Global Anti Inflammatory Peptide Market.

    Which application segment is expected to hold the largest market share in the Global Anti Inflammatory Peptide Market?

    The therapeutic application segment is expected to hold the largest market share in the Global Anti Inflammatory Peptide Market.

    What are the major factors driving the growth of the Global Anti Inflammatory Peptide Market?

    Major factors driving the growth of the Global Anti-inflammatory Peptide Market include the rising prevalence of chronic inflammatory diseases, increasing research and development activities, and growing awareness of the benefits of anti-inflammatory peptides.

    What are the challenges faced by the Global Anti Inflammatory Peptide Market?

    Challenges faced by the Global Anti-inflammatory Peptide Market include high cost of production, regulatory hurdles, and lack of skilled workforce.

    What are the opportunities for growth in the Global Anti Inflammatory Peptide Market?

    Opportunities for growth in the Global Anti-inflammatory Peptide Market include untapped potential in emerging markets, technological advancements, and increasing demand for personalized medicine.

    What are the key trends in the Global Anti Inflammatory Peptide Market?

    Key trends in the Global Anti-inflammatory Peptide Market include the development of novel delivery systems, combination therapies, and the use of artificial intelligence in drug discovery.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials